Tag: Mediar Therapeutics

Mediar Therapeutics Announces Oversubscribed $76 Million Series B Financing and Clinical Advancement of First-in-Class Fibrosis Portfolio

Mediar Therapeutics Announces Oversubscribed $76 Million Series B Financing and Clinical Advancement of First-in-Class Fibrosis Portfolio

Series B Co-led by New Investors Amplitude Ventures and ICG MTX-474 Global Phase 2a study Initiated in Systemic Sclerosis (SSc) MTX-463 Global Phase 2a Study in Idiopathic Pulmonary Fibrosis (IPF) Enrolling & Partnered with Lilly…

Read More Read More

Cambridge Massachusetts based Mediar Therapeutics is raising $31,761,186.00 in New Equity Investment.

Cambridge Massachusetts based Mediar Therapeutics is raising $31,761,186.00 in New Equity Investment.

Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Mediar Therapeutics is raising $31,761,186.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Meredith Fisher played a…

Read More Read More